Gilles A. Salles, MD, PhD: Controversies in Indolent Lymphoma
Dr. Gilles Salles, discusses indolent lymphoma research presented at ASCO 2012. Follicular lymphoma (FL) has been the most extensively studied and was the focus of the discussion on first-line treatment options for patients. In addition, the RELEVANCE Trial is discussed. This interview was filmed at the American Society of Clinical Oncology Annual Meeting in Chicago 2012. Gilles A. Salles, MD, PhD, of the Hospices Civils de Lyon and Université de Lyon, France.